In early October 2026, the European Commission adopted its first decision to select two medical devices for joint clinical assessment under the EU Health Technology Assessment (#HTA).
What does this mean for medtech innovators?
Tune into the latest episode of MedTech ON AIR, recorded live from our booth at The MedTech Forum 2026, where Frédérique Debroucker, Senior Director, EHPR at Medtronic, unpacks how the new HTA framework is set to shape the path from innovation to patient access.
The key takeaway: don't wait to prepare. Review your pipeline, anticipate future evidence requirements, and make full use of the tools available under the new framework.
Podden och tillhörande omslagsbild på den här sidan tillhör
MedTech Europe. Innehållet i podden är skapat av MedTech Europe och inte av,
eller tillsammans med, Poddtoppen.
